By a GenomeWeb staff reporter
NEW YORK (GenomeWeb News) – Evotec said today that it will use its high-throughput compound screening and assay development technologies to identify small molecule modulators for a target selected by Stockholm-based Active Biotech.
Registering provides access to this and other free content.
Already have an account?Login Now.
Vivek Murthy is no longer the surgeon general of the US, the Associated Press reports.
People around the globe took to the streets to support science — some with signs.
Parents who learn of their increased genetic risk of disease also contend with telling their children about theirs, the New York Times writes.
In PLOS this week: loci linked to body mass index measurements, long non-coding RNA expression and urothelial carcinoma prognosis, and more.
This online seminar will provide an overview of the use of liquid biopsies for cancer recurrence monitoring with a particular focus on colorectal cancer.
This webinar will provide an overview of an RNA-seq protocol that has been optimized to study small RNA species such as microRNAs.
This webinar will discuss a target enrichment workflow for high-confidence detection of variants.
This webinar will discuss RNA sequencing as an alternative to immunohistochemistry (IHC) in selecting patients for cancer immunotherapy.